Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Levity vs T2D.com

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #95Desk pick
Levity

Levity is a telehealth weight loss provider dispensing FDA-approved branded GLP-1 medications only, with no compounded options.

Marked down on: Premium pricing, roughly 1,199 to 1,599 per month

FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.

vs
Dispatch #422
T2D.com

T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.

Marked down on: No pricing published on the public website — must register to see costs

Levity takes this head-to-head with the higher Desk Score, 76/100 (C) against 51/100 (C) for T2D.com. T2D.com still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Levity

76/100

C

Overall

T2D.com

51/100

C

Price transparency

84
30

State access

66
42

Molecule range

79
66

Onboarding speed

72
56

Support responsiveness

83
70

Licensing & trust

66
68

The spec sheet

FieldLevityT2D.com
Semaglutide$1,199/mo (all doses, bundle, brand-name)$999/mo (starting dose, compounded)
Tirzepatide$1,299/mo (all doses, bundle, brand-name)$999/mo (starting dose, compounded)
Coverage36 states1 state
Brand-nameYesCompounded only
Oral optionInjectable onlyInjectable only
Best forPatients wanting all-inclusive branded GLP-1 pens and willing to pay premium cash prices.Readers who want diabetic GLP-1 access.
Desk Score76/100C51/100C

The verdict

Desk pick — Levity

Levity takes this head-to-head with the higher Desk Score, 76/100 (C) against 51/100 (C) for T2D.com. T2D.com still holds its ground where its strengths line up with yours.

Choose Levity if…

Patients wanting all-inclusive branded GLP-1 pens and willing to pay premium cash prices.

$1,199/mo (all doses, bundle, brand-name) sema · $1,299/mo (all doses, bundle, brand-name) tirz · 36 states

FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.

Choose T2D.com if…

Readers who want diabetic GLP-1 access.

$999/mo (starting dose, compounded) sema · $999/mo (starting dose, compounded) tirz · 1 state

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Levity · T2D.com.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.